What Are Anti-Nephrin Antibodies After Kidney Transplant?

When your child receives a kidney transplant for congenital nephrotic syndrome (Finnish type), you may be told that the original disease “does not come back.” However, some children develop a condition where protein leaks into the urine again. This is often caused by anti-nephrin antibodies. This can feel frightening and mimic a recurrence of the disease, but it is actually a treatable process caused by the immune system, not the original disease returning ^[1][2].

Why Does This Happen?

Children with the Finnish type of congenital nephrotic syndrome are typically born with a genetic mutation (often the “Fin-major” mutation) that prevents their bodies from producing a specific kidney protein called nephrin ^[1][2]. Nephrin is an essential building block that helps the kidneys filter blood and keep protein in the body.

Because your child’s immune system grew and developed without ever “seeing” normal nephrin, it doesn’t recognize it as a natural part of the body. When your child receives a new, healthy kidney transplant, that new kidney functions normally and naturally produces nephrin. In some cases, the child’s immune system mistakenly views this new, healthy nephrin as a foreign invader—much like a virus or bacteria—and creates antibodies (defense proteins) to attack it ^[1][2].

What Are the Symptoms?

When these anti-nephrin antibodies attack the new kidney’s filter, it causes a temporary leak ^[2]. The primary sign is proteinuria (high levels of protein in the urine) ^[1][2].

Because you cannot see microscopic protein with the naked eye, this complication is often caught early by your care team through routine post-transplant urine tests—which is why keeping up with frequent lab appointments is so critical. At home, the physical signs look very similar to the nephrotic syndrome your child had before the transplant: you might notice frothy, foamy urine or the return of swelling (edema) ^[1]. This similarity is exactly why parents often confuse this immune reaction with a disease “recurrence.”

How Is It Treated?

It is important to know that anti-nephrin antibody development is a well-recognized complication that your child’s transplant team knows how to handle. The goal of treatment is to remove the antibodies and stop the immune system from making more. Treatment usually involves:

• Plasma exchange (plasmapheresis): A process that filters the child’s blood to physically remove the anti-nephrin antibodies ^[1][2].
• Targeted medications: Drugs like cyclophosphamide or anti-CD20 therapies (such as rituximab) are used to calm the immune system so it stops producing the attacking antibodies ^[1][2].

What Does This Mean for the Transplant?

The development of anti-nephrin antibodies does not mean the transplant is failing or that the new kidney is a bad match. Once the antibodies are treated and the protein leakage stops (a state called remission), the long-term health and function of the transplanted kidney are generally excellent ^[1][2]. Studies show that this temporary immune reaction does not significantly harm the long-term survival of the new kidney once it is successfully managed ^[1][2]. After remission is achieved, your child will continue to have routine monitoring to ensure the kidney remains healthy.